Acrivon

$7.2M revenue • 40 employees • United States

Last Updated May 8, 2025

Company Overview

Company Name

Acrivon

Address

United States

Approx. Annual Revenue

$7.2M

Employees

40

Established

2018

About Acrivon

Acrivon is a biotechnology company developing targeted therapies to improve the lives of patients. Headquartered in the United States, Acrivon is leveraging its proprietary proteomics-based patient selection approach to match drug mechanisms to the biological drivers of cancer, with the goal of delivering better outcomes for patients suffering from common and pressing cancer types.

Business Profile

Read from the Acrivon website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Complete pipeline and science pages
Footer copyright year
2026

Recent changes

What changed on the Acrivon website and Google listing, as detected by Coldlytics on each visit.

  1. Estimated revenue band moved from $1M-2.5M to $5M-10M

  2. Estimated headcount moved from 6-10 to 21-50 employees

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Biotech & Life Sciences Companies near MA

Browse all Biotech & Life Sciences companies in Massachusetts →

Frequently Asked Questions about Acrivon

Categories

Technologies Used

Key Decision Makers

Peter Blume President
LinkedIn
Chi La Sr. Clinical Trial Manager
LinkedIn